Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts

Magnetic Resonance Molecular Imaging of Extradomain B Fibronectin Improves Imaging of Pancreatic Cancer Tumor Xenografts

The survival of pancreatic cancer patients can be greatly improved if their disease is detected at an early, potentially curable stage. Magnetic resonance molecular imaging (MRMI) of oncoproteins is a promising strategy for accurate, early detection of the disease. Here, we test the hypothesis that...

Full description

Bibliographic Details
Main Authors: Peter Qiao, Nadia R. Ayat, Amita Vaidya, Songqi Gao, Wenyu Sun, Samuel Chou, Zheng Han, Hannah Gilmore, Jordan M. Winter, Zheng-Rong Lu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Oncology
Subjects:
MRI
extradomain B fibronectin
pancreatic cancer
molecular imaging
tumor microenvironment
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.586727/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.586727/full

Similar Items